1. Rahimtoola, S. H. 1989. Perspective on valvular heart disease: An update. J. Am. Coll. Cardiol. 14:1-23.

2. Starr, A., Fessler C. L., Grunkemeier, G., and He, G. W. 2002. Heart valve replacement surgery: past, present and future. Clin. Exp. Pharmacol. Physiol. 29:735-738.

3. Silver, M. D. and Butany, J. 1987. Mechanical heart valves: Methods of examination, complications, modes of failure. Hum. Pathol. 18:577-585.

4. Anderson, J. M. 1993. Cardiovascular device retrieval and evaluation. Cardiovasc. Pathol. 2(Suppl):199S-208S.

5. Schoen, F. J. 1989. Interventional and Surgical Cardiovascular Pathology: Clinical Correlations and Basic Principles. Philadelphia: WB Saunders.

6. Butany, J., d'Amati, G., Fornasier, V., Silver, M. D., and Sanders, G. E. 1990. Detailed examination of complete bioprosthetic heart valves. ASAIO Trans. 36:M414-M417.

7. Schoen, F. J. 1995. Approach to the analysis of cardiac valve prostheses as surgical pathology or autopsy specimens. Cardiovasc. Pathol. 4:241-255.

8. Schoen, F. J. 1999. Evaluation of explanted cardiovascular prostheses. In: von Recum, A. F., ed., Handbook of Biomaterials Evaluation: Scientific, Technical and Chemical Testing of Implant Material, 2nd Edition. Washington: Taylor & Francis, pp. 671-686.

9. Schoen, F. J., Anderson, J. M., Didisheim, P., et al. 1990. Ventricular assist device (VAD) pathology analyses: guidelines for clinical studies. J. Appl. Biomater. 1:49-56.

10. Borovetz, H. S., Ramasamy, N., Zerbe, T. R., and Portner, P. M. 1995. Evaluation of an implantable ventricular assist system for humans with chronic refractory heart failure. Device explant protocol. ASAIO J. 41:42-48.

11. Wagner, W. R., Johnson, P. C., Kormos, R. L., and Griffith, B. P. 1993. Evaluation of bioprosthetic valve-associated thrombus in ventricular assist device patients. Circulation 88:203-209.

12. Fyfe, B. and Schoen, F. J. 1993. Pathologic analysis of 34 explanted Symbion ventricular assist devices and 10 explanted Jarvik-7 total artificial hearts. Cardiovasc. Pathol. 2:187-197.

13. Canizales, S., Charara, J., Gill, F., et al. 1982. Expanded polytetrafluoroethylene prostheses as secondary blood access sites for hemodialysis: Pathological findings in 29 excised grafts. Can. J. Surg. 54:17-26.

14. Downs, A. R., Guzman, R., Formichi, M., et al. 1991. Etiology of prosthetic anas-tomotic false aneurysms: Pathologic and structural evaluation in 26 cases. Can. J. Surg. 34:53-58.

15. Guidoin, R., Chakfe, N., Maurel, S., et al. 1993. Expanded polytetrafluoroethylene arterial prostheses in humans: histopathological study of 298 surgical excised grafts. Biomaterials 14:678-693.

16. Anderson, P. G., Bajaj, R. K., Baxley, W. A., and Roubin, G. S. 1992. Vascular pathology of balloon-expandable flexible coil stent in humans. J. Am. Coll. Cardiol. 19:372-381.

17. Van Beusekom, H. M. M., van der Giessen, W. J., van Suylen, R. J., Bos, E., Bosman, F.T., and Serruys, P. W. 1993. Histology after stenting of human saphenous vein bypass grafts: Observations from surgically excised grafts 3 to 320 days after stent implantation. J. Am. Coll. Cardiol. 21:45-54.

18. Farb, A., Sangioregi, G., Carter, A. J., et al. 2002. Pathology of acute and chronic coronary stenting in humans. Circulation 105:2932-2933.

19. Schwartz, R. S., Edelman, E. R., Carter, A., et al. 2002. Drug-eluting stents in preclinical studies: Recommended evaluation from a consensus group. Circulation 106:1867-1873.

20. Jabcobs, T. S., Won, J., Gravereaux, E. C., et al. 2003. Mechanical failure of prosthetic human implants: A 10-year experience with aortic stent graft devices. J. Vasc. Surg. 37:16-26.

21. Anderson, J. M., Shoen, F. J., Brown, S. A., and Merritt, K. 2004. Implant retrieval and evaluation. In: Ratner, B. D., Hoffman, A. S., Shoen, F. J., and Lemons, J. E., eds., Biomaterials Science, 2nd Edition. New York: Elsevier, pp. 771-782.

22. Savage, R. A. 1991. New law to require medical device injury report. CAP Today, July, pp. 40.

23. Kahan, J. S. 1991. The Safe Medical Devices Act of 1990. Med. Dev. Diagn. Ind., Jan, p. 67.

24. Atkins, C. W. 1995. Results with mechanical cardiac valvular prostheses. Ann. Thorac. Surg. 60:1836-1844.

25. Turina, J., Hess, O. M., Turina, M., and Krayenbuehl, H. P. 1993. Cardiac bioprostheses in the 1990s. Circulation 88:775-781.

26. Bloomfield, P., Wheatley, D. J., Prescott, R. J., and Miller, H. C. 1991. Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N. Engl. J. Med. 324:573-579.

27. Hammermeister, K. E., Sethi, G. K., Henderson, W. G., Oprian, C., Kim, T., and Rahimtoola, S. 1993. A comparison of outcomes in men 11 years after heart-valve replacement mechanical valve or bioprosthesis. N. Engl. J. Med. 328:1289-1296.

28. Schoen, F. J. 2001. Pathology of heart valve substitution with mechanical and tissue prostheses. In: Cardiovascular Pathology, 3rd Ed., Silver, M. D., Gotlieb, A. I., Schoen, F. J., eds., WB Saunders pp. 629-667.

29. Davis, P. F. and Bowyer, D. E. 1975. Scanning electron microscopy: Arterial endothelial integrity after fixation at physiological pressure. Atherosclerosis 21:463-69.

30. Clowes, A. W., Gown, A. M., Hanson, S. R., and Reidy, M. A. 1985. Mechanisms of arterial graft failure. 1. Role of cellular proliferation in early healing of PTFE prostheses. Am. J. Pathol. 118:43-54.

31. Palatianos, G. M., Dewanjee, M. K., Panoutsopoulos, G., Kapadvanjwala, M., Novak, S., and Sfakianakis, G. N. 1994. Comparative thrombogenicity of pacemaker leads. Pacing Clin. Electrophysiol. 17:141-145.

32. Reidy, M. A., Chao, S. S., Kirkman, T. R., and Clowes, A. W. 1986. Endothelial regeneration. VI. Chronic nondenuding injury in baboon vascular grafts. Am. J. Pathol. 123:432-439.

33. Levy, R. J., Schoen, F. J., Levy, J. T., Nelson, A. C., Howard, S. L., and Oshry, L. J. 1993. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcuta-neously in rats. Am. J. Pathol. 113:143-155.

34. Schoen, F. J., Hirsch, D., Bianco, R. W., and Levy, R. J. 1994. Onset and progression of calcification in porcine aortic bioprosthetic valves implanted as orthotopic mitral valve replacements in juvenile sheep. J. Thorac. Cardiovasc. Surg. 108:880-887.

35. Schoen, F. J., Titus, J. L., and Lawrie, G. M. 1983. Autopsy-determined causes of death after cardiac valve replacement. J. Am. Med. Assoc. 249:899-902.

36. Schoen, F. J. and Hobson, C. E. 1985. Anatomic analysis of removed prosthetic heart valves: causes of failure of 33 mechanical valves and 58 bioprostheses, 1980-1983. Human Pathol. 16:549-559.

37. Schoen, F. J. and Levy, R. J. 1999. Tissue heart valves: current challenges and future research perspectives. J. Biomed. Mater. Res. 47:439-465.

38. Butany, J. and Leask, R. 2001. The failure modes of biological prosthetic heart valves. J. Long Term Eff. Med. Implants 11:115-135.

39. Schoen, F. J. 1999. Future directions in tissue heart valves: Impact of recent insights from biology and pathology. J. Heart Valve Dis. 8:350-358.

40. O'Rourke, R. A., Peterson, K. L., and Braunwald, N. S. 1973. Postoperative hemodynamic evaluation of a new fabric-covered ball-valve prosthesis. Circulation 47,48(Suppl 3):74-79.

41. Braunwald, N. S. and Bonchek, L. I. 1967. Prevention of thrombus on rigid prosthetic heart valves by the ingrowth of autogenous tissue. J. Thorac. Cardiovasc. Surg. 54:630-638.

42. Braunwald, N. S. and Morrow, A. G. 1968. Tissue ingrowth and the rigid heart valve. J. Thorac. Cardiovasc. Surg. 56:307-319.

43. Blackstone, E. H., Kirklin, J. W., Pluth, J. R., Turner, M. E., and Parr, G. V. S. The performance of the Braunwald-Cutter aortic prosthetic valve.

44. Schoen, F. J., Goodenough, S. H., Ionescu, M. I., and Braunwald, N. S. 1984. Implications of late morphology of Braunwald-Cutter mitral heart valve prosthe-ses. J. Thorac. Cardiovasc. Surg. 88:208-216.

45. Murphy, D. A., Levine, F. H., Buckley, M. J., et al. 1983. Mechanical valves: a comparative analysis of the Starr-Edwards and Bjork-Shiley prostheses. J. Thorac. Cardiovasc. Surg. 86:746-752.

46. Blot, W. J., Ibrahim, M. A., Ivey, T. D., et al. 2005. Twenty-five-year experience with the Bjork-Shiley convexoconcove heart valve. A continuing clinical concern. Circulation 111:2850-2857.

47. Orszulak, T. A., Schaff, H. V., DeSmet, J. -M., Danielson, G. K., Pluth, J. R., and Puga, F. J. 1993. Late results of valve replacement with Bjork-Shiley valve (19731982). J. Thorac. Cardiovasc. Surg. 105:302-312.

48. Shoen, F. J., Levy, R. J., and Piehler H. R. 1992. Pathological considerations in replacement cardiac valves. Cardiovasc. Pathol. 1:29-52.

49. de Mol, B. A. J. M., Koornneef, F., and van Gaalen, G. L. 1995. What can be done to improve the safety of heart valves? Intl. J. Risk Safety Med. 6:157-168.

50. Van Gorp, M. J., Steyerberg, E. W., and van der Graff, Y. 2004. Decision guidelines for prophylactic replacement of Bjork-Shiley convexo-concave heart valves: impact on clinical practice. Circulation 109:2092-2096.

51. O'Neill, W. W., Chandler, J. G., Gordon, R. E., et al. 1995. Radiographic detection of strut separations in Bjork-Shiley convexo-concave mitral valves. N. Engl. J. Med. 333:414-419.

52. Plemons, T. D. and Hovenga, M. 1995. Acoustic classification of the state of artificial heart valves. J. Acoust. Soc. Am. 97:2326-2333.

53. Schoen, F. J., Kujovich, J. L., Webb, C. L., and Levy, R. J. 1987. Chemically determined mineral content of explanted porcine aortic valve bioprostheses: Correlation with radiographic assessment of calcification and clinical data. Circulation 76:1061-1066.

54. Tomazic, B. B., Edwards, W. D., and Schoen, F. J. 1995. Physicochemical characterization of natural and bioprosthetic heart valve calcific deposits. Implications for prevention. Ann. Thorac. Surg. 60(2 Suppl):S322-S327.

55. Schoen, F. J., Levy, R. J., Nelson, A. C., Bernhard, W. F., Nashef, A., and Hawley, M. A. 1985. Onset and progression of experimental bioprosthetic heart valve calcification. Lab. Invest. 52:523-532.

56. Schoen, F. J., Tsao, W., and Levy, R. J. 1986. Calcification of bovine pericardium used in cardiac valve bioprostheses: implications for the mechanisms of bioprosthetic tissue mineralization. Am. J. Pathol. 123:134-145.

57. Schoen, F. J., Kujovich, J. L., Levy, R. J., et al. 1988. Bioprosthetic heart valve pathology: clinicopathologic features of valve failure and pathobiology of calcification. Cardiovasc. Clin. 18:289-317.

58. Schoen, F. J., Levy, R. J., Hilbert, S. L., and Bianco, R. W. 1992. Antimineralization treatments for bioprosthetic heart valves: assessment of efficacy and safety. J. Thorac. Cardiovasc. Surg. 104:1285-1288.

59. Shoen, F. J. and Levy, R. J. 2005. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann. Thorac. Surg. 79:1072-1080.

60. Flomenbaum, M. A. and Schoen, F. J. 1993. Effects of fixation back-pressure and antimineralization treatment on the morphology of porcine aortic bioprosthetic valves. J. Thorac. Cardiovasc. Surg. 105:154-164.

61. Robinson, M. J., Hildner, F. J., and Greenberg, J. J. 1971. Disc variance of Beall mitral valve. Ann. Thor. Surg. 11:11-17.

62. Silver, M. D. and Wilson, G. J. 1977. The pathology of wear in the Beall Model 104 heart valve prosthesis. Circulation 56:617-622.

63. More, R. B., Haubold, A. D., and Bokros, J. C. 2004. Pyrolytic carbon for long-term medical implants. In: Ratner, B. D., Hoffman, A. S, Schoen, F. J., Lemons, E., eds., Biomaterials Science: An Introduction to Materials in Medicine, 2nd Ed. New York: Elsevier, pp.170-182.

64. Schoen, F. J., Titus, J. L., and Lawrie, G. M. 1982. Durability of pyrolytic carbon-containing heart valve prostheses. J. Biomed. Mater. Res. 16:559-570.

65. Haubold, A. D. 1994. On the durability of pyrolytic carbon in-vivo. Med. Prog. Tech. 20:201-208.

66. Kirklin, J., Smith, D., Novick, W., et al. 1993. Long-term function of cryopreserved aortic homografts. A ten-year study. J. Thorac. Cardiovasc. Surg. 106:154-166.

67. Grunkemeier, G. L. and Bodnar, E. 1994. Comparison of structural valve failure among different "models" of homograft valves J. Heart Valve Dis. 3:556-560.

68. Mitchell, R. N., Jonas, R. A., Schoen, F. J. 1998. Pathology of explanted cryopreserved allograft heart valves: comparison with aortic valves from orthoto-pic heart transplants. J. Thorac. Cardiovasc. Surg. 115:118-127.

69. Gross, J. M., Shu, M. C., Dai, F. F., Ellis, J., and Yoganathan, A. P. 1996. A microstructural flow analysis within a bileaflet mechanical heart valve hinge. J. Heart Valve Dis. 5:581-590.

70. Ellis, J. T., Healy, T. M., Fontaine, A. A., Saxena, R., and Yoganathan. A. P. 1996. Velocity measurements and flow patterns within the hinge region of Medtronic Parallel bileaflet mechanical valve with clear housing. J. Heart Valve Dis. 5:572-573.

71. Gao, Z. B., Hosein, N., Dai, F. F., and Hwang, N. H. 1999. Pressure and flow fields in the hinge region of bileaflet mechanical heart valves. J. Heart Valve Dis. 8:197-205.

72. Schoen, F. J. 1998. Pathologic findings in explanted clinical bioprosthetic valves fabricated from photooxidized bovine pericardium. J. Heart Valve Dis. 7:174179.

73. Butterfield, M. and Fisher, J. 2000. Fatigue analysis of clinical bioprosthetic heart valves manufactured using photooxidized bovine pericardium. J . Heart Valve Dis. 9:161-166.

0 0

Post a comment